Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.

Date publication

février 2017

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier

Tous les auteurs :
Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, Tilly H, Vera P, Meignan MA, Becker S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27754905

Résumé

The purpose of this study was to compare in a large series of peripheral T cell lymphoma, as a model of diffuse disease, the prognostic value of baseline total metabolic tumor volume (TMTV) measured on F-FDG PET/CT with adaptive thresholding methods with TMTV measured with a fixed 41% SUV threshold method.

Mots clés

Computer Simulation, Europe, epidemiology, Female, Fluorodeoxyglucose F18, pharmacokinetics, Humans, Image Interpretation, Computer-Assisted, methods, Lymphoma, T-Cell, metabolism, Male, Middle Aged, Models, Biological, Models, Statistical, Neoplasm Staging, Positron Emission Tomography Computed Tomography, methods, Prevalence, Prognosis, Proportional Hazards Models, Radiopharmaceuticals, pharmacokinetics, Reproducibility of Results, Risk Factors, Sensitivity and Specificity, Survival Analysis, Tumor Burden

Référence

J. Nucl. Med.. 2017 02;58(2):276-281